A frequent question from healthcare leaders and stakeholders is: what pharmacy companies are in 340B? The answer is more nuanced than a simple list of participating organizations. Unlike traditional programs with defined membership, the 340B program does not “certify” or “approve” specific pharmacy companies. Instead, pharmacy participation is determined through contractual relationships with covered entities.
Pharmacies play a critical role in 340B program execution—especially through contract pharmacy arrangements that extend access to patients beyond hospital-owned or clinic-based dispensing locations. However, not all pharmacy companies operate the same way within 340B, and the structure of these relationships has major implications for compliance, performance, and audit risk.
This article explains how pharmacy companies participate in 340B, the types of pharmacy organizations involved, and what covered entities should consider when building or optimizing their pharmacy networks.
Need help evaluating your contract pharmacy network strategy? Contact Cooper Strategy
How Pharmacies Participate in the 340B Program
Pharmacies Are Not “340B Entities”
Pharmacies themselves are not covered entities under the 340B statute. They do not independently qualify for 340B pricing or program participation. Instead, they participate on behalf of covered entities.
This means:
- The covered entity owns the 340B relationship
- The covered entity is responsible for compliance
- The pharmacy acts as a dispensing partner
Contract Pharmacy Arrangements
Pharmacies participate in 340B through contract pharmacy agreements. These agreements allow:
- Covered entities to dispense 340B drugs through external pharmacies
- Patients to access medications in convenient community locations
- Covered entities to extend their reach beyond owned pharmacies
Contract pharmacies are now a central component of many 340B programs.
Types of Pharmacy Companies Involved in 340B
National Retail Pharmacy Chains
Large national pharmacy chains are among the most common participants in 340B contract pharmacy networks. These organizations offer:
- Broad geographic coverage
- High prescription volume
- Established infrastructure
Covered entities often partner with national chains to expand patient access.
Regional and Independent Pharmacies
Regional chains and independent pharmacies also participate in 340B. These pharmacies may offer:
- Strong community relationships
- Localized patient access
- Flexibility in partnership structures
Independent pharmacies can be especially valuable in rural or underserved areas.
Specialty Pharmacy Providers
Specialty pharmacies play a critical role in dispensing high-cost medications, including:
- Oncology therapies
- Biologics
- Rare disease treatments
Because specialty drugs drive a significant portion of 340B savings, specialty pharmacy relationships are often a key focus area.
Health-System-Owned Pharmacies
Some covered entities operate their own retail or specialty pharmacies. These in-house pharmacies:
- Provide direct control over dispensing
- Reduce reliance on external partners
- Allow for tighter integration with clinical workflows
Even organizations with in-house pharmacies may still use contract pharmacies to expand reach.
Key Characteristics of 340B Pharmacy Participation
Dispensing Role Only
Pharmacies dispense medications to patients but do not determine eligibility. Eligibility is determined by:
- The covered entity
- Its systems and policies
- Its third-party administrator (TPA), if applicable
Fee-Based Compensation
Contract pharmacies are typically compensated through:
- Dispensing fees
- Administrative fees
- Shared savings arrangements (in some cases)
They do not retain the full 340B discount.
Data Sharing and Integration
Pharmacies must provide data back to the covered entity to support:
- Claim reconciliation
- Eligibility validation
- Replenishment processes
- Audit documentation
Data integrity is critical.
Operational Differences Across Pharmacy Companies
Variation in Data Capabilities
Not all pharmacies provide the same level of:
- Data transparency
- Reporting capabilities
- Integration support
Covered entities must evaluate these capabilities carefully.
Differences in Compliance Support
Some pharmacy companies offer:
- Structured 340B workflows
- Dedicated support teams
- Compliance-focused processes
Others may require more oversight from the covered entity.
Specialty vs. Retail Complexity
Specialty pharmacies often involve:
- More complex documentation
- Higher financial stakes
- Increased audit scrutiny
Retail pharmacies typically involve higher volume but lower per-claim value.
Compliance Responsibilities When Working With Pharmacies
Covered Entity Accountability
Even when working with pharmacy companies, the covered entity remains responsible for:
- Eligibility determination
- Duplicate discount prevention
- Documentation integrity
- Audit readiness
Responsibility cannot be delegated.
Contract Pharmacy Oversight
Covered entities must actively monitor:
- Claim eligibility
- Prescriber mapping
- Documentation completeness
- Reversal and correction activity
Lack of oversight is a common audit finding.
Contractual Clarity
Agreements with pharmacy companies should clearly define:
- Roles and responsibilities
- Data requirements
- Compliance expectations
- Performance metrics
Clear contracts reduce ambiguity and risk.
Risks Associated With Pharmacy Partnerships
High Volume Increases Exposure
Large pharmacy networks generate high claim volume, increasing both:
- Savings opportunities
- Compliance risk
Referral-Based Complexity
Pharmacy claims often involve:
- External prescribers
- Referral-based eligibility
- Specialty medications
These factors increase audit scrutiny.
Data Misalignment
Inconsistent data between pharmacy systems and TPA/EHR systems can lead to:
- Missed claims
- Incorrect eligibility determinations
- Audit findings
Best Practices for Managing 340B Pharmacy Relationships
Evaluate Pharmacy Performance
Monitor:
- Claim capture rates
- Reversal rates
- Data quality
- Financial contribution
Limit Network to High-Value Partners
More pharmacies do not always mean better results. Focus on:
- High-performing locations
- Strategic geographic coverage
- Strong data integration
Maintain Continuous Oversight
Implement:
- Routine claim sampling
- Performance reviews
- Compliance audits
Align Pharmacy Strategy With Program Goals
Ensure pharmacy relationships support:
- Patient access
- Financial sustainability
- Compliance integrity
The Evolving Role of Pharmacy Companies in 340B
Increasing Scrutiny
Contract pharmacy arrangements continue to face scrutiny from:
- Manufacturers
- Regulators
- Policymakers
Covered entities must be prepared to defend these relationships.
Shift Toward Data Transparency
Pharmacy partners are expected to provide more detailed and timely data to support compliance.
Integration With Emerging Models
Rebate models and other evolving program structures will further impact how pharmacy companies participate in 340B.
👉 Cooper Strategy helps organizations design, optimize, and govern contract pharmacy networks for maximum performance and compliance.
Contact Cooper Strategy
Conclusion
There is no single list of “pharmacy companies in 340B.” Instead, pharmacies participate through contractual relationships with covered entities. These relationships are essential for expanding patient access and maximizing program value—but they also introduce complexity and risk.
Covered entities that approach pharmacy partnerships strategically, maintain strong oversight, and align operations with compliance requirements are best positioned to succeed in today’s 340B environment.
Frequently Asked Questions About Pharmacy Companies in 340B
Are pharmacies officially part of the 340B program?
Pharmacies are not covered entities under the 340B program and do not independently qualify for participation. Instead, they participate through contractual relationships with covered entities. These contract pharmacy arrangements allow pharmacies to dispense 340B drugs on behalf of the covered entity. While pharmacies play a critical operational role, the covered entity retains full responsibility for compliance, eligibility determination, and program oversight.
Do all pharmacy companies participate in 340B?
Not all pharmacy companies participate in 340B, but many do through contract pharmacy agreements. Participation depends on whether a pharmacy has entered into a contractual relationship with a covered entity. Some large national chains, regional pharmacies, and specialty providers are commonly involved, but participation varies widely based on strategy, geography, and operational capabilities.
What is the difference between retail and specialty pharmacies in 340B?
Retail pharmacies typically dispense high volumes of lower-cost medications, while specialty pharmacies handle complex, high-cost drugs such as biologics and oncology therapies. Specialty pharmacy claims often carry higher financial value but also greater compliance risk and documentation requirements. Covered entities must manage both types carefully to optimize savings and maintain compliance.
Who is responsible for compliance in contract pharmacy arrangements?
The covered entity is fully responsible for compliance, even when working with contract pharmacies. This includes ensuring patient eligibility, preventing duplicate discounts, maintaining documentation, and monitoring claim accuracy. Pharmacies support dispensing and data reporting, but they do not assume compliance responsibility.
How can Cooper Strategy help optimize pharmacy partnerships in 340B?
Cooper Strategy helps organizations evaluate pharmacy network performance, identify high-risk areas, improve data integration, and design governance frameworks that support compliance and financial performance. We ensure pharmacy partnerships align with both operational goals and regulatory expectations.
👉 Contact Cooper Strategy